{"id":14384,"date":"2020-08-14T16:25:21","date_gmt":"2020-08-14T20:25:21","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=14384"},"modified":"2020-08-14T18:52:17","modified_gmt":"2020-08-14T22:52:17","slug":"08-10-20-08-14-20-ipo-summary","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/08-10-20-08-14-20-ipo-summary\/","title":{"rendered":"08.10.20-08.14.20 IPO Summary – CureVac Closes +250% on Day 1 (!)"},"content":{"rendered":"


\n\"\"<\/a><\/p>\n

It was another week…and another couple of record-setting IPO performances that continues to send the whole market abuzz.\u00a0<\/span><\/p>\n

\"\"<\/a><\/b><\/p>\n

CureVac B.V. (CVAC)<\/b> priced a full-size deal, 13.33mm shares, at the high-end of the range, $16.00, and <\/span>opened at $44.00 for a gain of 175.0% at first trade<\/b>. This was the <\/span>third highest opening print for an IPO all year<\/b> behind NKarta Inc (NKTX) and BigCommerce Inc (BIGC). \u00a0The stock closed its opening session at $55.90 for a gain of 249.4% (!).\u00a0<\/strong><\/span><\/p>\n

\"\"<\/a><\/p>\n

KE Holdings Inc (BEKE) <\/b>\u00a0priced a full-size deal, 106.0mm ADSs, at $20.00 ($1.00 above the range) and<\/span> opened at $35.06 for a gain of 75.3% at first trade<\/b>. The stock closed its opening session at $37.44 ,or 87.2% above issue, which tallied it as the best first-day pop for a billion-dollar IPO since 2000.\u00a0<\/span><\/p>\n

\"\"<\/a><\/p>\n

The lone domestic software deal of the week<\/span>, Duck Creek Technologies Inc (DCT)<\/b> priced a full-size deal, 15.0mm shares, at $27.00 ($2.00 above the upwardly-revised range) and <\/span>opened at $42.00 for a gain of 55.5% at first trade<\/b>.<\/span><\/p>\n

\"\"<\/a>
\n<\/a><\/p>\n

NETSTREIT Corp (NTST)<\/b> priced 12.5mm shares at $18.00 ($1.00 below range) and <\/span>opened flat at $18.00.\u00a0<\/b><\/p>\n

Looking ahead to this week, <\/span>there are three IPOs currently on the calendar:<\/b><\/p>\n

Debuting Wednesday (8\/19)<\/strong><\/span><\/p>\n

Harmony Biosciences Holdings Inc (HRMY) — <\/b>They are a commercial-stage pharmaceutical company focused on developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet medical needs.<\/p>\n

Inhibrx, Inc. (INBX) — <\/b>They are a clinical-stage biotechnology company with a pipeline of novel biologic therapeutic candidates, developed using our protein engineering expertise and proprietary single domain antibody, or sdAb, platform.<\/p>\n

Debuting Friday (8\/21)<\/strong><\/span><\/p>\n

Nano-X Imaging Ltd. (NNOX) — <\/b>They are focused on applying their proprietary medical imaging technology to make diagnostic medicine more accessible and affordable across the globe.<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":14278,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,2058,1536],"tags":[2188,2186,2187,2189],"class_list":["post-14384","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ipo","category-spotlight","category-subscriber-content","tag-beke","tag-cvac","tag-dct","tag-ntst"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/14384","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=14384"}],"version-history":[{"count":5,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/14384\/revisions"}],"predecessor-version":[{"id":14392,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/14384\/revisions\/14392"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/14278"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=14384"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=14384"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=14384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}